Monte Rosa Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Monte Rosa Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2021 to Q3 2024.
  • Monte Rosa Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $27.4M, a 6.95% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $27.4M -$2.04M -6.95% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $27.9M -$2.47M -8.12% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $28.4M -$2.11M -6.92% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $28.8M -$6.02M -17.3% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 $29.4M -$9.13M -23.7% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $30.4M -$16.7M -35.5% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $30.5M Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $34.8M +$34.8M Dec 31, 2022 10-K 2024-03-14
Q3 2022 $38.5M Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $47.1M Jun 30, 2022 10-Q 2022-08-11
Q4 2021 $0 Dec 31, 2021 10-K 2023-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.